1.T.Dzimbova, E. Miladinova , S. Mohr, R. Detcheva, A. Balacheva, M. G. Schmid, T. Pajpanova. Sulfo- and oxy-analogues of Arginine: Synthesis, Analysis and Preliminary Biological Screening. CroaticaChemicaacta, 84 (3), 447-453, 2011. IF 0,831
2.T. Dzimbova, I. Iliev, R. Detcheva, A. Balacheva, T.Pajpanova. In vitro assessment of the cytotoxic effects of hydrazide derivatives of sulfoarginines in 3T3 and HepG2 cells. Collection of czeshoslovak chemical communication symposium Series, 13, 34-36, 2011. IF 0,853
3.T. Dzimbova, I. Iliev, K. Georgiev, R. Detcheva, A. Balacheva, T. Pajpanova. In vitro assessment of the cytotoxic effects of hydrazide derivatives of unnatural amino acids. Proceedings of the 22nd American Peptide Symposium, 392-393, 2011.
4.T. Dzimbova, I. Iliev, K. Georgiev, R. Detcheva, A. Balacheva, T. Pajpanova. In vitro assessment of thecytotoxic effects of sulfo-arginine analogues and their hydrazide derivatives in 3T3 and HepG2 cells. Biotechnol&BiotechnolEq., 26, 180-184. IF - 0.760, 2012. ISSN: 1310-2818.
5.A. Balacheva, I. Iliev,R.Detcheva, T. Dzimbova, T. Pajpanova, E. Golovinsky. In vitro assessment of the cytotoxic effects of novel RGD analogues. BioDiscovery, 4, 1, ISSN 2050-2966, ISSN 2050-2958, 2012.
6.A. Balacheva, R. Detcheva, T. Pajpanova. Biological activity of RGD peptides.
Proceedigs of the fourth workshop on experimental models and methods in biomedical research, may 27-29, ISSN 1314-9091, 2013.
7.. Georgiev, T.Dzimbova, I.Iliev, A.Balacheva, R.Detcheva, M.Schmid,T. Pajpanova. Growth inhibition of HepG2 cell line by canavanine, norcanavanine and their hydrazide derivatives.Der Pharma Chemica, 6(1), 360-369, 2014.
8.A. Balacheva, T.Dzimbova, R.Detcheva, et al. Synthesis, analysis and cytotoxic effects of new RGD-mimetics . Amino acids,47, 8, 1687-1687, 2015.